S015 Red Flags and Emergencies in Dermatology
DESCRIPTION
It is often believed that dermatology does not involve life-threatening situations, with many observers considering skin disorders as being only “skin deep” and of no more than aesthetic/cosmetic importance. The truth is that the dermatology unit is no stranger to life-threatening skin diseases or serious and lethal systemic diseases with cutaneous manifestations. Moreover, dermatologists are not spared the possibility of needing to deal with severely sick patients. Indeed, dermatologists are frequently the first physicians to examine a patient, thus becoming responsible for making the initial diagnosis of grave conditions that require urgent attention. The present session will provide descriptions of a selection of acute, severe, life-threatening skin diseases, with the aim of guiding dermatologists in rapid and accurate diagnostic decision-making, and be better able to carry out the appropriate urgent interventions, for these conditions.
LEARNING OBJECTIVES
Diagnose acute life-threatening skin diseases or serious and lethal systemic diseases with cutaneous manifestations.
Identify critical dermatological situations, recognize red flags that signal real emergencies, and differentiate them from everyday skin ailments that do not pose any immediate danger or emergency.
Describe the pathological aspects of life-threatening skin diseases, better able to carry out the appropriate urgent interventions, and be well-informed about the most up-to-date treatments available for these conditions.
SCHEDULE
1:00 PM
Introduction
Ronni Wolf, MD, IFAAD
1:15 PM
Life-threatening Stings, Bites, and Marine Envenomation
Dirk Michael Elston, MD, FAAD
1:35 PM
Eschars: Signs of Life-threatening Disorders
Theodore Rosen, MD, FAAD
2:05 PM
Dermatological Urgent Care: When Banalities Surprise You
Warren R. Heymann, MD, FAAD
2:25 PM
Use of Biologic Agents and Immunomodulators in Cutaneous Emergencies
Mark Lebwohl, MD, FAAD
2:45 PM
Severe, Acute Adverse Cutaneous Drug Reactions
Roni Dodiuk-Gad, MD
3:05 PM
Erythroderma: Diagnosing and Treating the "Red Man"
Lawrence C Parish, MD, FAAD
3:25 PM
Catastrophes in Cosmetic Procedures
Anthony V. Benedetto, DO, FAAD
3:45 PM
Questions & Answers
DIRECTOR
Ronni Wolf, MD, IFAAD
SPEAKERS
Anthony V. Benedetto, DO, FAAD
Roni Dodiuk-Gad, MD
Dirk Michael Elston, MD, FAAD
Warren R. Heymann, MD, FAAD
Mark Lebwohl, MD, FAAD
Lawrence C Parish, MD, FAAD
Theodore Rosen, MD, FAAD
HANDOUTS
DISCLOSURES
Anthony V. Benedetto, DO, FAAD
AbbVie – Investigator(Fees), Stockholder Private Company(Fees); BioDelivery Systems, Inc. – Stockholder(Stock Options); Bristol-Myers Squibb – Stockholder(Stock); Castle Biosciences, Inc – Advisory Board(Honoraria); GSK PLC – Stockholder Private Company(Stock); Ipsen – Speaker(Honoraria); IQVIA – Investigator(Fees); Merz Pharmaceuticals, LLC – Stockholder Public Company(No Compensation Received); Organogenesis, Inc. – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Stock); Stratapharma – Consultant(Honoraria), Investigator(Honoraria), Speaker(Honoraria);
Roni Dodiuk-Gad, MD
No financial relationships exist with ineligible companies.
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Warren R. Heymann, MD, FAAD
No financial relationships exist with ineligible companies.
Mark Lebwohl, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Added Health – Consultant (1099 relationship)(Honoraria); Aikium – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); J&J Innovative Medicine – Consultant (1099 relationship)(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Mayne Pharma Group – Consultant (1099 relationship)(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); Mirum Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Revolo Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Lawrence C Parish, MD, FAAD
No financial relationships exist with ineligible companies.
Theodore Rosen, MD, FAAD
No financial relationships exist with ineligible companies.
Ronni Wolf, MD, IFAAD
No financial relationships exist with ineligible companies.